ERCC5 (P28715) variants and mutations
ERCC5 (also known as P28715) is a human protein-coding gene encoding a DNA excision repair protein ERCC-5 protein. It makes one of the two strand incisions required to remove bulky DNA lesions during nucleotide-excision repair and also supports repair-associated transcriptional responses. Biallelic pathogenic variants can cause xeroderma pigmentosum group G, Cockayne syndrome, or combined phenotypes. This analysis covers 1,891 ERCC5 variants and mutations. Of these, 65% have computational variant effect predictions. Disease context includes xeroderma pigmentosum group G, xeroderma pigmentosum-Cockayne syndrome complex, and Xeroderma pigmentosum complementation group G. Example ERCC5 variants include G2E, G2R, and G2V.
Variant analysis overview
- Gene: ERCC5
- Protein: P28715
- UniProt accession: P28715
- Organism: Homo sapiens
- Variants analyzed: 1891
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 1,748 unspecified-consequence records; 67 synonymous variants; 57 missense variants; 5 stop-gained variants; 10 frameshift variants; 2 splice-region variants; 2 in-frame deletions; 1 substitution
- Prediction scores: 1,223 variants have prediction scores (65% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: xeroderma pigmentosum group G, xeroderma pigmentosum-Cockayne syndrome complex, Xeroderma pigmentosum complementation group G, COFS syndrome, xeroderma pigmentosum, hereditary disease, ovarian cancer, prostate carcinoma, melanoma, cutaneous melanoma, pancreatic neoplasm, carcinoma of liver and intrahepatic biliary tract.
Protein structure and variant hotspots
- Protein features: 1 domains; 7 binding sites; 3 post-translational modification sites.
- Structural context: 51 variants have structural context.
- PTM context: 5 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ERCC5 variants
Examples include G2E, G2R, G2V, G2W, G2G, V3D, V3F, V3I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2E (p.Gly2Glu), TOPMed rs1242514429, gnomAD rs1242514429
- G2R (p.Gly2Arg), TOPMed rs1178467021, gnomAD rs1178467021
- G2V (p.Gly2Val), TOPMed rs1242514429, gnomAD rs1242514429, CADD 29.20
- G2W (p.Gly2Trp), TOPMed rs1178467021, gnomAD rs1178467021, CADD 32.00, PolyPhen-2 1.00
- G2G (p.Gly2Gly), rs755260246, gnomAD 13-102846272-G-A, CADD 5.64
- V3D (p.Val3Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V3F (p.Val3Phe), ExAC rs781364064, gnomAD rs781364064, CADD 29.80, PolyPhen-2 1.00
- V3I (p.Val3Ile), ExAC rs781364064, gnomAD rs781364064, CADD 28.20, PolyPhen-2 1.00
- V3A (p.Val3Ala), gnomAD 13-102846274-T-C, CADD 29.70, PolyPhen-2 1.00
- V3V (p.Val3Val), gnomAD 13-102846275-C-A, CADD 7.47
- Q4H (p.Gln4His), ExAC rs753121419, gnomAD rs753121419, CADD 21.30, PolyPhen-2 0.10
- Q4P (p.Gln4Pro), rs2501509040, ClinGen CA388565039, ClinVar RCV003154765, CADD 30.00, PolyPhen-2 0.95, Likely pathogenic, Ovarian cancer
- Q4Q (p.Gln4Gln), gnomAD 13-102846278-G-A, CADD 12.80
- G5R (p.Gly5Arg), ExAC rs756544378, TOPMed rs756544378, gnomAD rs756544378, CADD 32.00, PolyPhen-2 1.00
- L6F (p.Leu6Phe), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Variant assessed as somatic; moderate impact.
- L6P (p.Leu6Pro), Ensembl rs113590348
- L6L (p.Leu6Leu), gnomAD 13-102846284-C-G, CADD 11.80
- K8N (p.Lys8Asn), Ensembl rs1881954549
- K8E (p.Lys8Glu), gnomAD 13-102846288-A-G, CADD 32.00, PolyPhen-2 0.98
- K8K (p.Lys8Lys), gnomAD 13-102846290-G-A, CADD 13.60
- L9Q (p.Leu9Gln), gnomAD 13-102846292-T-A, CADD 32.00, PolyPhen-2 1.00
- L10L (p.Leu10Leu), gnomAD 13-102846296-G-T, CADD 13.80
- E11A (p.Glu11Ala), rs1266019512, ClinGen CA388565082, ClinVar RCV001109704, Ensembl rs1266019512, AlphaMissense 0.20, MetaLR 0.22, Uncertain significance, Xeroderma pigmentosum, group G
- E11G (p.Glu11Gly), Ensembl rs1266019512, Uncertain significance
- E11Q (p.Glu11Gln), ExAC rs778247692, gnomAD rs778247692, CADD 32.00, PolyPhen-2 1.00
- E11K (p.Glu11Lys), gnomAD 13-102846297-G-A, CADD 32.00, PolyPhen-2 1.00
- E11D (p.Glu11Asp), gnomAD 13-102846299-G-T, CADD 27.10, PolyPhen-2 1.00
- C12G (p.Cys12Gly), TOPMed rs1566461950
- C12R (p.Cys12Arg), rs1566461950, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, TOPMed rs1566461950, AlphaMissense 0.09, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- C12S (p.Cys12Ser), TOPMed rs1566461950, Uncertain significance, Cerebrooculofacioskeletal syndrome 3; Xeroderma pigmentosum, group G
- C12Y (p.Cys12Tyr), Ensembl rs2140511557
- S13F (p.Ser13Phe), ExAC rs749851993, TOPMed rs749851993, gnomAD rs749851993, CADD 27.60, PolyPhen-2 0.99
- S13P (p.Ser13Pro), TOPMed rs1881955244, CADD 26.90, PolyPhen-2 0.98
- S13S (p.Ser13Ser), gnomAD 13-102846305-C-G, CADD 6.16
- G14R (p.Gly14Arg), ExAC rs771547408, gnomAD rs771547408, CADD 28.60, PolyPhen-2 1.00
- G14V (p.Gly14Val), ExAC rs779651408, gnomAD rs779651408
- G14A (p.Gly14Ala), gnomAD 13-102846307-G-C, CADD 26.50, PolyPhen-2 0.94
- G14G (p.Gly14Gly), gnomAD 13-102846308-G-C, CADD 6.34
- R15W (p.Arg15Trp), Ensembl rs2140511578, CADD 24.60, PolyPhen-2 0.99
- R15R (p.Arg15Arg), gnomAD 13-102846309-C-A, CADD 10.00
- R15Q (p.Arg15Gln), gnomAD 13-102846310-G-A, CADD 26.50, PolyPhen-2 0.82
- Q16* (p.Gln16Ter), TOPMed rs1309171968
- Q16E (p.Gln16Glu), TOPMed rs1309171968
- Q16K (p.Gln16Lys), TOPMed rs1309171968
- Q16P (p.Gln16Pro), TOPMed rs1226729518
- Q16R (p.Gln16Arg), TOPMed rs1226729518, CADD 18.00, PolyPhen-2 0.02
- Q16Q (p.Gln16Gln), rs202038276, gnomAD 13-102846314-G-A, CADD 15.10
- V17A (p.Val17Ala), NCI-TCGA Cosmic COSV9995, Ensembl rs1595373084, Variant assessed as somatic; moderate impact.
- V17D (p.Val17Asp), Ensembl rs1595373084
- V17G (p.Val17Gly), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Ensembl rs1595373084, Variant assessed as somatic; moderate impact.
- V17F (p.Val17Phe), gnomAD 13-102846315-G-T, CADD 27.20, PolyPhen-2 0.88
- V17V (p.Val17Val), rs768374740, gnomAD 13-102846317-C-T, CADD 11.00
- S18N (p.Ser18Asn), Ensembl rs2140511599
- S18G (p.Ser18Gly), gnomAD 13-102846318-A-G, CADD 23.50, PolyPhen-2 0.33
- S18S (p.Ser18Ser), rs201240143, gnomAD 13-102846320-C-T, CADD 15.20
- P19L (p.Pro19Leu), rs34291397, ClinGen CA158939, cosmic curated COSV99053, ClinVar RCV000120832, CADD 24.50, PolyPhen-2 0.99, Conflicting interpretations, Inborn genetic diseases; Cerebrooculofacioskeletal syndrome 3; not specified
- P19S (p.Pro19Ser), Ensembl rs2140511603, CADD 25.10, PolyPhen-2 0.98
- P19A (p.Pro19Ala), gnomAD 13-102846321-C-G, CADD 24.00, PolyPhen-2 0.87
- P19P (p.Pro19Pro), gnomAD 13-102846323-C-G, CADD 5.21
- E20K (p.Glu20Lys), ExAC rs761699560, TOPMed rs761699560, gnomAD rs761699560, CADD 29.80, PolyPhen-2 1.00
- E20Q (p.Glu20Gln), ExAC rs761699560, TOPMed rs761699560, gnomAD rs761699560
- E20* (p.Glu20Ter), gnomAD 13-102846324-G-T, CADD 41.00
- E20E (p.Glu20Glu), rs1881957836, gnomAD 13-102846326-A-G, CADD 8.59
- A21G (p.Ala21Gly), rs2140511625, ClinGen CA388565148, ClinVar RCV003237535, Ensembl rs2140511625, AlphaMissense 0.15, MetaLR 0.24, Uncertain significance, not provided
- A21T (p.Ala21Thr), cosmic curated COSV57281, gnomAD rs1881957980, CADD 7.87
- A21S (p.Ala21Ser), gnomAD 13-102846327-G-T, CADD 11.20, PolyPhen-2 0.01
- A21E (p.Ala21Glu), gnomAD 13-102846328-C-A, CADD 23.10, PolyPhen-2 0.22
- A21A (p.Ala21Ala), rs200464030, gnomAD 13-102846329-G-A, CADD 8.59
- L22Q (p.Leu22Gln), gnomAD rs1396039188, CADD 31.00, PolyPhen-2 1.00
- E23K (p.Glu23Lys), NCI-TCGA Cosmic COSV5727, cosmic curated COSV57279, Variant assessed as somatic; moderate impact.
- E23* (p.Glu23Ter), gnomAD 13-102846333-G-T, CADD 43.00
- E23D (p.Glu23Asp), gnomAD 13-102846335-A-T, CADD 22.90, PolyPhen-2 0.41
- G24A (p.Gly24Ala), gnomAD rs1444733032
- G24E (p.Gly24Glu), gnomAD rs1444733032, CADD 32.00, PolyPhen-2 1.00
- G24D (p.Gly24Asp), gnomAD 13-102846331-TGGA, CADD 33.00
- G24G (p.Gly24Gly), gnomAD 13-102846338-G-C, CADD 12.40
- K25E (p.Lys25Glu), TOPMed rs1386839345, gnomAD rs1386839345, CADD 32.00, PolyPhen-2 1.00
- K25N (p.Lys25Asn), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Variant assessed as somatic; moderate impact.
- K25* (p.Lys25Ter), gnomAD 13-102846339-A-T, CADD 48.00
- I26M (p.Ile26Met), rs766329524, ClinGen CA388565182, cosmic curated COSV57281, ClinVar RCV003237534, AlphaMissense 0.32, MetaLR 0.22, Uncertain significance, not provided
- I26N (p.Ile26Asn), NCI-TCGA Cosmic COSV5728, cosmic curated COSV57281, CADD 32.00, PolyPhen-2 0.98, Variant assessed as somatic; moderate impact.
- I26S (p.Ile26Ser), Ensembl rs2140511653, CADD 32.00, PolyPhen-2 0.94
- I26V (p.Ile26Val), rs371937705, ClinGen CA7040959, ClinVar RCV001109706, ClinVar RCV002259081, CADD 20.70, PolyPhen-2 0.11, Benign/Likely benign, not provided; Xeroderma pigmentosum, group G; Hereditary cancer-predisposing syn
- I26T (p.Ile26Thr), gnomAD 13-102846343-T-C, CADD 32.00, PolyPhen-2 0.88
- I26I (p.Ile26Ile), rs766329524, gnomAD 13-102846344-C-T, AlphaMissense 0.32, MetaLR 0.22
- L27V (p.Leu27Val), NCI-TCGA Cosmic COSV9995, Variant assessed as somatic; moderate impact.
- L27L (p.Leu27Leu), rs1016196215, gnomAD 13-102846345-C-T, CADD 14.80
- A28D (p.Ala28Asp), rs267607281, ClinGen CA261269, ClinVar RCV000034376, UniProt VAR 075773, AlphaMissense 1.00, MetaLR 0.52, Pathogenic, Xeroderma pigmentosum, group G
- V29G (p.Val29Gly), Ensembl rs2140511665
- V29I (p.Val29Ile), Ensembl rs2140511662
- D30N (p.Asp30Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I31M (p.Ile31Met), TOPMed rs1882227120
- I31T (p.Ile31Thr), rs763654582, ClinGen CA7041053, ClinVar RCV003154774, ClinVar RCV004887719, CADD 26.90, PolyPhen-2 0.92, Conflicting interpretations, Ovarian cancer; not specified
- I31V (p.Ile31Val), TOPMed rs1452267228, gnomAD rs1452267228, CADD 24.10, PolyPhen-2 0.70
- I31I (p.Ile31Ile), gnomAD 13-102852122-T-C, CADD 10.50
- S32N (p.Ser32Asn), gnomAD rs1259251118
- I33I (p.Ile33Ile), gnomAD 13-102852128-T-A, CADD 8.18
- W34C (p.Trp34Cys), cosmic curated COSV63245, ESP rs373207563, ExAC rs373207563, TOPMed rs373207563, CADD 33.00, PolyPhen-2 0.99
- N36K (p.Asn36Lys), Ensembl rs2140517218
- Q37* (p.Gln37Ter), ExAC rs761470006
- A38P (p.Ala38Pro), Ensembl rs2140517226
- A38V (p.Ala38Val), NCI-TCGA TCGA novel, Ensembl rs2140517228, Variant assessed as somatic; moderate impact.
- A38T (p.Ala38Thr), gnomAD 13-102852141-G-A, CADD 32.00, PolyPhen-2 0.97
- A38A (p.Ala38Ala), rs764800560, gnomAD 13-102852143-A-T, CADD 5.54
- L39R (p.Leu39Arg), gnomAD 13-102852145-T-G, CADD 28.10, PolyPhen-2 0.98
- K40E (p.Lys40Glu), TOPMed rs1384929710, gnomAD rs1384929710, CADD 27.00, PolyPhen-2 0.43
- K40Q (p.Lys40Gln), TOPMed rs1384929710, gnomAD rs1384929710, CADD 25.90
- K40T (p.Lys40Thr), gnomAD 13-102852148-A-C, CADD 27.00, PolyPhen-2 0.55
- G41E (p.Gly41Glu), TOPMed rs1275853625, gnomAD rs1275853625
- R43Q (p.Arg43Gln), rs758174644, ClinGen CA7041058, cosmic curated COSV63247, ClinVar RCV003443226, CADD 24.40, PolyPhen-2 0.11, Uncertain significance, not provided
- R43W (p.Arg43Trp), rs750156480, ClinGen CA7041057, NCI-TCGA Cosmic COSV6324, cosmic curated COSV63244, CADD 23.20, PolyPhen-2 0.07, Uncertain significance, Hereditary cancer-predisposing syndrome; Xeroderma pigmentosum, group G
- R43R (p.Arg43Arg), gnomAD 13-102852158-G-C, CADD 0.67
- R45C (p.Arg45Cys), rs569799893, cosmic curated COSV10591, 1000Genomes rs569799893, ExAC rs569799893, CADD 22.90, PolyPhen-2 0.02, Variant assessed as somatic; moderate impact.
- R45H (p.Arg45His), rs140917545, cosmic curated COSV63248, 1000Genomes rs140917545, ESP rs140917545, CADD 16.30, PolyPhen-2 0.02, Uncertain significance, not provided
- R45S (p.Arg45Ser), gnomAD 13-102852162-C-A, CADD 20.20, PolyPhen-2 0.04
- H46Q (p.His46Gln), 1000Genomes rs1047768, ESP rs1047768, ExAC rs1047768, TOPMed rs1047768, Benign
- H46M (p.His46Met), rs1187206011, gnomAD 13-102852163-GC-G, CADD 23.10
- H46H (p.His46His), rs1047768, gnomAD 13-102852167-T-C, CADD 0.40
- G47E (p.Gly47Glu), TOPMed rs1331207226
- G47R (p.Gly47Arg), cosmic curated COSV10467, gnomAD rs1417696811, CADD 26.10, PolyPhen-2 0.93
- N48T (p.Asn48Thr), gnomAD 13-102852172-A-C, CADD 22.50, PolyPhen-2 0.84
- S49L (p.Ser49Leu), Ensembl rs2140517290
- S49S (p.Ser49Ser), rs1882229359, gnomAD 13-102852176-A-G, CADD 0.12
- I50T (p.Ile50Thr), TOPMed rs1377503714, gnomAD rs1377503714, CADD 24.30, PolyPhen-2 0.64
- I50V (p.Ile50Val), ExAC rs781276062, TOPMed rs781276062, gnomAD rs781276062, CADD 7.05, PolyPhen-2 0.03
- N52D (p.Asn52Asp), ESP rs141212999, TOPMed rs141212999, gnomAD rs141212999, CADD 25.80, PolyPhen-2 0.79
- N52H (p.Asn52His), ESP rs141212999, TOPMed rs141212999, gnomAD rs141212999, CADD 25.10
- P53H (p.Pro53His), NCI-TCGA TCGA novel, Ensembl rs2140517307, Variant assessed as somatic; moderate impact.
- P53L (p.Pro53Leu), cosmic curated COSV10745, Ensembl rs2140517307, CADD 23.30, PolyPhen-2 0.00
- H54D (p.His54Asp), TOPMed rs1333614535, gnomAD rs1333614535, Uncertain significance
- H54R (p.His54Arg), ExAC rs748185385, gnomAD rs748185385, CADD 25.50, PolyPhen-2 0.28
- H54Y (p.His54Tyr), rs1333614535, ClinGen CA388566861, ClinVar RCV001761455, TOPMed rs1333614535, CADD 25.30, PolyPhen-2 0.97, Uncertain significance, not provided
- H54N (p.His54Asn), gnomAD 13-102852189-C-A, CADD 25.40, PolyPhen-2 0.94
- L55F (p.Leu55Phe), TOPMed rs977942010, gnomAD rs977942010, CADD 26.00, PolyPhen-2 0.99
- L55H (p.Leu55His), Ensembl rs1882230374
- L56F (p.Leu56Phe), cosmic curated COSV10525, TOPMed rs1444427189, gnomAD rs1444427189, CADD 26.20, PolyPhen-2 0.94
- L56R (p.Leu56Arg), 1000Genomes rs570321828, ExAC rs570321828, gnomAD rs570321828, CADD 28.30, PolyPhen-2 0.99
- L56V (p.Leu56Val), gnomAD 13-102852195-C-G, CADD 25.10, PolyPhen-2 0.94
- L56L (p.Leu56Leu), gnomAD 13-102852197-C-A, CADD 9.56
- T57I (p.Thr57Ile), TOPMed rs1353597671, gnomAD rs1353597671, CADD 22.90, PolyPhen-2 0.25
- T57N (p.Thr57Asn), TOPMed rs1353597671, gnomAD rs1353597671
- T57P (p.Thr57Pro), TOPMed rs924662120
- T57S (p.Thr57Ser), TOPMed rs924662120, CADD 25.40, PolyPhen-2 0.55
- T57T (p.Thr57Thr), gnomAD 13-102852200-T-C, CADD 8.86
- L58F (p.Leu58Phe), ExAC rs749572902, TOPMed rs749572902, gnomAD rs749572902, CADD 23.70, PolyPhen-2 0.98
- L58S (p.Leu58Ser), gnomAD rs1282864712, CADD 28.50, PolyPhen-2 0.98
- L58W (p.Leu58Trp), gnomAD 13-102852202-T-G, CADD 28.40, PolyPhen-2 1.00
- F59Y (p.Phe59Tyr), TOPMed rs1882231314, CADD 27.10, PolyPhen-2 0.83
- H60Q (p.His60Gln), rs771389207, NCI-TCGA Cosmic COSV6324, cosmic curated COSV63246, ExAC rs771389207, CADD 25.20, Variant assessed as somatic; moderate impact.
- H60R (p.His60Arg), gnomAD rs1199571357, CADD 25.50, PolyPhen-2 0.93
- H60I (p.His60Ile), gnomAD 13-102852203-GT-G, CADD 32.00
- H60H (p.His60His), gnomAD 13-102852209-T-C, CADD 8.97
- R61G (p.Arg61Gly), gnomAD rs1439118079, CADD 28.80, PolyPhen-2 0.70
- R61Q (p.Arg61Gln), ExAC rs774884182, TOPMed rs774884182, gnomAD rs774884182, CADD 33.00, PolyPhen-2 0.79
- R61W (p.Arg61Trp), gnomAD rs1439118079, CADD 32.00, PolyPhen-2 0.96
- R61L (p.Arg61Leu), gnomAD 13-102852208-ATCG, CADD 33.00
- R61R (p.Arg61Arg), rs746325552, gnomAD 13-102852212-G-A, CADD 9.56
- L62F (p.Leu62Phe), gnomAD 13-102852213-C-T, CADD 25.60, PolyPhen-2 0.80
- L62L (p.Leu62Leu), rs1566464277, gnomAD 13-102852215-C-G, CADD 9.76
- C63S (p.Cys63Ser), ExAC rs772466904, gnomAD rs772466904, CADD 28.20, PolyPhen-2 1.00
- C63Y (p.Cys63Tyr), ExAC rs772466904, gnomAD rs772466904
- C63F (p.Cys63Phe), gnomAD 13-102852217-G-T, CADD 29.10, PolyPhen-2 1.00
- L65F (p.Leu65Phe), rs776140428, ClinGen CA7041070, cosmic curated COSV63244, ClinVar RCV002572847, CADD 25.70, PolyPhen-2 0.80, Uncertain significance, not specified; not provided
- L65L (p.Leu65Leu), gnomAD 13-102852224-C-G, CADD 9.91
- L66I (p.Leu66Ile), Ensembl rs2140517372
- L66V (p.Leu66Val), Ensembl rs2140517372
- L66F (p.Leu66Phe), gnomAD 13-102852224-C-CT, CADD 28.70
- F67C (p.Phe67Cys), rs761224800, ClinGen CA388566943, ClinVar RCV002296602, AlphaMissense 0.90, MetaLR 0.35, Uncertain significance, not provided
- F67L (p.Phe67Leu), NCI-TCGA TCGA novel, Ensembl rs1882232677, CADD 29.60, PolyPhen-2 0.34, Variant assessed as somatic; moderate impact.
- F67S (p.Phe67Ser), ExAC rs761224800, gnomAD rs761224800, AlphaMissense 0.90, MetaLR 0.35
- F67I (p.Phe67Ile), gnomAD 13-102852228-T-A, CADD 28.90, PolyPhen-2 0.39
- R69* (p.Arg69Ter), rs1882232971, ClinGen CA388566955, NCI-TCGA Cosmic COSV6324, cosmic curated COSV63247, CADD 39.00, Pathogenic
- R69L (p.Arg69Leu), gnomAD rs747957305, CADD 33.00, PolyPhen-2 0.97
- R69P (p.Arg69Pro), gnomAD rs747957305
- R69Q (p.Arg69Gln), rs747957305, NCI-TCGA Cosmic COSV6324, cosmic curated COSV63247, gnomAD rs747957305, CADD 32.00, PolyPhen-2 0.90, Variant assessed as somatic; moderate impact.
- R69G (p.Arg69Gly), gnomAD 13-102852234-C-G, CADD 25.40, PolyPhen-2 0.97
- I70V (p.Ile70Val), gnomAD 13-102852237-A-G, CADD 23.80, PolyPhen-2 0.26
- R71C (p.Arg71Cys), rs1400329743, ClinGen CA388566967, NCI-TCGA Cosmic COSV6324, cosmic curated COSV63244, CADD 32.00, PolyPhen-2 0.99, Uncertain significance, not specified
- R71H (p.Arg71His), rs587778293, ClinGen CA159006, ClinVar RCV000120849, ClinVar RCV001109708, CADD 31.00, PolyPhen-2 0.99, Uncertain significance, Xeroderma pigmentosum, group G
- R71L (p.Arg71Leu), gnomAD 13-102852241-G-T, CADD 32.00, PolyPhen-2 0.94
Public ERCC5 analysis runs
- ERCC5 analysis run — ERCC5 (1,891 variants) — completed 2026-08-21